Thrombotic microangiopathy and the kidney: A nephropathologist's perspective

Diagnostic Histopathology

Volumn 19, Issue 5, 2013, Pages 158-165

  Chang, Anthony ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Alternative complement pathway; Antiphospholipid antibody syndrome; Haemolytic uraemic syndrome; Malignant hypertension; Scleroderma; Thrombocytopenic purpura

Indexed keywords

BEVACIZUMAB; BLEOMYCIN; BORTEZOMIB; CISPLATIN; CLOPIDOGREL; COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; GEMCITABINE; IMMUNOGLOBULIN M; MITOMYCIN; PRASUGREL; QUINIDINE; QUININE; RAPAMYCIN; RIFAMPICIN; RITUXIMAB; SORAFENIB; SUNITINIB; TACROLIMUS; TICLOPIDINE; VINCRISTINE;

ANTIBODY MEDIATED REJECTION; ANTIPHOSPHOLIPID SYNDROME; BLOOD VESSEL INJURY; CAPILLARY BASEMENT MEMBRANE; CELL SURVIVAL; COMPLEMENT SYSTEM; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; ECLAMPSIA; GENE MUTATION; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; HELLP SYNDROME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; KIDNEY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALIGNANT HYPERTENSION; NONHUMAN; PATHOLOGIST; PREECLAMPSIA; RADIATION EXPOSURE; RADIATION INJURY; RADIATION NEPHROPATHY; REVIEW; SCLERODERMA; SICKLE CELL NEPHROPATHY; SYNDROME; THROMBOCYTE AGGREGATION INHIBITION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 84892386849     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2013.02.004     Document Type: Review

References (18)

1. Orth D., Khan A.B., Naim A., et al. Shiga toxin activates complement and binds factor h: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 2009, 182:6394-6400.
2. Kavanagh D., Goodship T.H. Atypical hemolytic uremic syndrome. Curr Opin Hematol 2010, 17:432-438.
3. Peyvandi F., Palla R., Lotta L.A. Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica 2010, 95:1444-1447.
4. Hosler G.A., Cusumano A.M., Hutchins G.M. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. Arch Pathol Lab Med 2003, 127:834-839.
5. van den Born B.J., van der Hoeven N.V., Groot E., et al. Association between thrombotic microangiopathy and reduced adamts13 activity in malignant hypertension. Hypertension 2008, 51:862-866.
6. Stillman I.E., Karumanchi S.A. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007, 18:2281-2284.
7. Eremina V., Jefferson J.A., Kowalewska J., et al. Vegf inhibition and renal thrombotic microangiopathy. N Engl J Med 2008, 358:1129-1136.
8. Fakhouri F., Jablonski M., Lepercq J., et al. Factor h, membrane cofactor protein, and factor i mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome. Blood 2008, 112:4542-4545.
9. Gropp K., Weber N., Reuter M., et al. Beta(2)-glycoprotein i, the major target in antiphospholipid syndrome, is a special human complement regulator. Blood 2011, 118:2774-2783.
10. Batal I., Domsic R.T., Medsger T.A., Bastacky S. Scleroderma renal crisis: a pathology perspective. Int J Rheumatol 2010, 2010:543704.
11. Di Nisio M., Baudo F., Cosmi B., et al. Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the italian society for haemostasis and thrombosis (siset). Thromb Res 2012, 129:e177-e184.
12. Nasr S.H., Markowitz G.S., Sentman R.L., D'Agati V.D. Sickle cell disease, nephrotic syndrome, and renal failure. Kidney Int 2006, 69:1276-1280.
13. Kim L., Garfinkel M.R., Chang A., Kadambi P.V., Meehan S.M. Intragraft vascular occlusive sickle crisis with early renal allograft loss in occult sickle cell trait. Hum Pathol 2011, 42:1027-1033.
14. Chang A., Hingorani S., Kowalewska J., et al. Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature. Clin J Am Soc Nephrol 2007, 2:1014-1023.
15. Blake-Haskins J.A., Lechleider R.J., Kreitman R.J. Thrombotic microangiopathy with targeted cancer agents. Clin Cancer Res 2011, 17:5858-5866.
16. Kreuter J., Winters J.L. Drug-associated thrombotic microangiopathies. Semin Thromb Hemost 2012, 38:839-844.
17. McCall S.J., Tuttle-Newhall J.E., Howell D.N., Fields T.A. Prognostic significance of microvascular thrombosis in donor kidney allograft biopsies. Transplantation 2003, 75:1847-1852.
18. Chang A., Kowalewska J., Smith K.D., Nicosia R.F., Alpers C.E. A clinicopathologic study of thrombotic microangiopathy in the setting of igA nephropathy. Clin Nephrol 2006, 66:397-404.